Loading...

Revolution Medicines, Inc.

RVMD•NASDAQ
Healthcare
Biotechnology
$135.30
$0.82(0.61%)
U.S. Market opens in 49h 13m

Revolution Medicines, Inc. (RVMD) Stock Overview

Explore Revolution Medicines, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap28.2B
P/E Ratio-22.87
EPS (TTM)$-5.96
ROE-0.63%
Fundamental Analysis

AI Price Forecasts

1 Month$104.05
3 Months$140.06
1 Year Target$92.17

RVMD Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Revolution Medicines, Inc. (RVMD) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 63.43, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $92.17.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -22.87 and a market capitalization of 28.2B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
0.61%
5-Day Change
-9.49%
1-Month Change
41.65%
3-Month Change
15.02%
6-Month Change
148.35%
Year-to-Date (YTD) Change
69.87%
1-Year Change
250.70%
3-Year Change
487.49%
5-Year Change
215.46%
All-Time (Max) Change
368.17%

Contact Information

https://www.revmed.com
650 481 6801
700 Saginaw Drive, Redwood City, CA, 94063

Company Facts

616 Employees
IPO DateFeb 13, 2020
CountryUS
Actively Trading

Frequently Asked Questions